EPTIS
BAM Logo

Search a Proficiency Testing (PT) scheme in the database

Country
Page 1 of 2 (Hits 1 to 20 of 36)
ID
Country
PT provider
PT scheme
Last changed
1009007 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva] 2023-01-31
PT name (Clinical PT - Molecular Biology - Coronavirus (SARS-CoV2): saliva)
Scheme name in national language (EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2): saliva)
Tested property (Molecular Biology - Coronavirus (SARS-CoV2): saliva)

1050992 France CTCB CTCB RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] RNA SARS-CoV2 (virology) [ARN SARS-CoV2 (virologie)] 2023-05-24
PT name (RNA SARS-CoV2 (virology))
Scheme name in national language (ARN SARS-CoV2 (virologie))
Test item (Detection of SARS-CoV2 RNA)
Tested property (ARN SARS-CoV2 - cell culture supernatant)

1051761 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Sequencing: Coronavirus (SARS-CoV2) [EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)] Clinical PT - Sequencing: Coronavirus (SARS-CoV2) [EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2)] 2023-05-29
PT name (Clinical PT - Sequencing: Coronavirus (SARS-CoV2))
Scheme name in national language (EP Clínico - Sequenciamento: Sequenciamento: Coronavírus (SARS-Cov-2))

134427 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Water Microbiology Scheme - (QWAS) Water Microbiology Scheme - (QWAS) 2021-03-01
Tested property (SARS-CoV-2) (Detection of SARS-CoV-2) (Optional quantification of SARS-CoV-2 (Trial))
Testing method (2 x 1.5 ml vial (A & B) of non-infectious, SARS-CoV-2 virus (whole genome) 1 x >100ml sterile water diluent 1 x >20g sterile sludge matrix)

138199 United States Collaborative Testing Services Collaborative Testing Services CTS Agriculture Laboratory Proficiency (ALP) Program: Water CTS Agriculture Laboratory Proficiency (ALP) Program: Water 2019-05-23
Tested property (Sum Cations, SAR, ADJ-SAR)

143893 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Cosmetics and Toiletries Scheme (COSMETICS) Cosmetics and Toiletries Scheme (COSMETICS) 2023-09-11
Tested property (Relevant to SARS-CoV-2 pandemic)

302644 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing Environmental Hygiene Monitoring Scheme- HYGIENE Environmental Hygiene Monitoring Scheme- HYGIENE 2021-09-06
Test item (Surface testing (swab rinsate) for SARS-CoV-2 molecular)
Tested property (SARS-CoV-2)

437169 Germany INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories Virus Genome Detection – Coronaviruses [Virusgenom-Nachweis – Coronaviren] Virus Genome Detection – Coronaviruses [Virusgenom-Nachweis – Coronaviren] 2020-04-15
Remarks () - qualitative, SARS-CoV-2 (RNA) - quantitative, SARS-CoV-2 (RNA) - qualitative Next Terms: June)
Tested property (differentiation between SARS-CoV-2, MERS coronavirus and other human coronaviruses (samples which contain the SARS-CoV-2 and/or MERS coronavirus are inactivated))

690909 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease) 2020-06-09
PT name (ILT-U-2072 - Respiratory protective devices (relevant to SARS-CoV-2 virus / COVID-19 disease))
Tested property (Requirements, testing, marking for COVID-19)

690914 Argentina ILT - Interlaboratory Test S.A. ILT - Interlaboratory Test S.A. Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112 2020-09-16
PT name (Face mask (relevant to SARS-CoV-2 virus / COVID-19 disease) - ILT-U-2091 / ILT-U-2097 / ILT-U-2100 / ILT-U-2112)

696054 Germany DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH DRRR - Deutsches Referenzbüro für Ringversuche und Referenzmaterialien GmbH Medical face masks (EN 14683) / filtering half masks (EN 149) [Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)] Medical face masks (EN 14683) / filtering half masks (EN 149) [Medizinische Gesichtsmasken (EN 14683) / Filtrierende Halbmasken (EN 149)] 2021-10-29
Remarks (PT relevant to SARS-CoV-2 virus / COVID-19)

699949 United Kingdom UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for Immunology, Immunochemistry & Allergy UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies 2023-05-30
PT name (UK NEQAS for SARS-CoV-2 / COVID-19 Antibodies)
Tested property (SARS-CoV-2 / COVID-19 Antibodies)

705717 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)] Clinical PT - Molecular Biology Coronavírus (SARS-CoV2) [EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2)] 2023-01-31
PT name (Clinical PT - Molecular Biology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - Biologia Molecular Coronavírus (SARS-CoV2))
Tested property (Coronavírus (SARS-CoV2))

705734 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation [EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ] Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation [EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação ] 2020-09-10
PT name (Clinical PT - Immunology Coronavírus (SARS-CoV2): Automation)
Scheme name in national language (EP Clínico - Imunologia Coronavírus (SARS-CoV2): Automação)

705752 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - TLR Coronavírus (SARS-CoV2): antigen [EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno] Clinical PT - TLR Coronavírus (SARS-CoV2): antigen [EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno] 2020-09-10
PT name (Clinical PT - TLR Coronavírus (SARS-CoV2): antigen)
Scheme name in national language (EP Clínico - TLR Coronavírus (SARS-CoV2): antígeno)
Tested property (Coronavírus (SARS-CoV2))

705758 Brazil ControlLab Controle de Qualidade para Laboratórios Ltda ControlLab Controle de Qualidade para Laboratórios Ltda Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] Clinical PT - TLR Immunology Coronavírus (SARS-CoV2) [EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2)] 2023-01-31
PT name (Clinical PT - TLR Immunology Coronavírus (SARS-CoV2))
Scheme name in national language (EP Clínico - TLR Imunologia Coronavírus (SARS-CoV2))

706310 Portugal Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ Programa Nacional de Avaliação Externa da Qualidade (PNAEQ) INSA DEP UAEQ SARS-CoV-2, PCR [SARS-CoV-2, PCR] SARS-CoV-2, PCR [SARS-CoV-2, PCR] 2021-03-25
PT name (SARS-CoV-2, PCR)
Scheme name in national language (SARS-CoV-2, PCR)
Tested property (SARS-CoV-2 virus)

769005 United Kingdom LGC AXIO Proficiency Testing LGC AXIO Proficiency Testing SARS-CoV-2 Proficiency Testing Scheme SARS-CoV-2 Proficiency Testing Scheme 2022-05-04
PT name (SARS-CoV-2 Proficiency Testing Scheme)
Test item (SARS-CoV-2 (Serological)- 3 x 0.75 ml samples for detection for the SARS-CoV-2 antibodies -NEW 2020) (SARS-CoV-2 (Molecular)- 2 x 1.5ml samples for SARS-CoV-2 virus -NEW 2020) (SARS-CoV-2 antigen - 3 x swab based samples (A, B, and C). Non-infectious simulated patient) (nasopharyngeal samples containing the SARS-CoV-2 nucleocapsid protein.) (SARS-CoV-2 (Molecular)- 2 x swab based samples. Non-infectious simulated nasopharyngeal samples)
Tested property (SARS-CoV-2 IgA, IgG, IgM, Total antibodies) (SARS-CoV-2 virus) (SARS-CoV-2 virus) (SARS-CoV-2 virus - The samples contain the whole genome) (SARS-CoV-2 virus - The samples contain the whole genome)
Testing method (The samples are derived from naturally occurring material collected via apheresis from patients that have recovered from COVID-19.)

789737 Australia RCPAQAP RCPAQAP Molecular Coronavirus SARS-CoV-2 Molecular Coronavirus SARS-CoV-2 2020-10-28
PT name (Molecular Coronavirus SARS-CoV-2)
Tested property (Coronavirus SARS-CoV2)

789879 Australia RCPAQAP RCPAQAP Molecular Respiratory Pathogens Molecular Respiratory Pathogens 2020-10-28
Tested property (Coronavirus (OC43, NL63, SARS-CoV-2))

Page 1 of 2 (Hits 1 to 20 of 36)
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5